Surprise! Massachusetts ban on gifts for doctors is back

When Massachusetts' House of Representatives passed a big healthcare bill in early July, drug and device makers and data firms thought they'd ducked a bullet or three, but the final bill, passed by both houses and signed by the governor a few weeks later, included a few nasty surprises for industry—including a code of conduct for drug marketers, an academic detailing program and stringent reporting requirements for payments made to physicians.

The House had gutted a proposed ban on gifts to physicians, but in its place, the legislation passed last night includes a provision calling for a “standard marketing code of conduct” to be “no less restrictive” than PhRMA's recently revised Code on Interactions with Healthcare Professionals and that from the Advanced Medical Technology Association. In essence, the code contains all the elements of the proposed gift ban, prohibiting most meals and other gifts to physicians. 

The legislation also requires that pharmas and device manufacturers operating in the commonwealth “disclose to the department of health the value, nature, purpose and particular recipient of any fee, payment, subsidy or other economic benefit with a value of at least $50” to healthcare professionals and institutions in the state by July 1 of each year—and face a fine of up to $5,000 for each violation. 
And the bill establishes an academic detailing program to be modeled on efforts in Pennsylvania, Vermont, Oregon and North Carolina and paid for through fees for subscriptions and contracts with private payers, funding from nongovernmental health access foundations and “undesignated drug litigation settlement funds associated with pharmaceutical marketing and pricing practices.

Absent from the final bill was a measure banning commercial provision of prescriber data. 

The timing of the measure had been pushed back in the House version, as similar laws are being challenged by health information firms elsewhere in New England, and lawmakers hoped to avoid a costly legal battle that might be resolved in other states. 
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


Investment in healthcare IT stands at an all-time high. The government has spent billions to promote EHR adoption. Yet the physician wish list is a mile long, while hospitals and patients are not where they need to be. To peel back the layers of what we've all been waiting for in the Great Data Capture of the 21st Century, and to review the changes enabling the healthcare data ecosystem to coexist, MM&M presents this e-Book. Click here.


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.